{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:14Z","timestamp":1790115914239,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.cardfail.2016.12.006","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T11:47:33Z","timestamp":1482234453000},"page":"340-344","source":"Crossref","is-referenced-by-count":15,"title":["Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy"],"prefix":"10.1016","volume":"23","author":[{"given":"Van-Khue","family":"Ton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7827-5977","authenticated-orcid":false,"given":"Aditya","family":"Bhonsale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha A.","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc K.","family":"Halushka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-7709","authenticated-orcid":false,"given":"Johana","family":"Almansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Tedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Wittstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2016.12.006_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11897-013-0149-5","article-title":"Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy","volume":"10","author":"Bishu","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2016.12.006_bib0025","first-page":"39","article-title":"Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction","volume":"8","author":"Ton","year":"2015","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007995.2012.754349","article-title":"The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology","volume":"29","author":"Plant\u00e9-Bordeneuve","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjcard.2011.03.069","article-title":"Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African American men","volume":"108","author":"Jacobson","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0050","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","volume":"50","author":"Cooper","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCHEARTFAILURE.109.932996","article-title":"Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE)","volume":"4","author":"Komajda","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0085","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/eurheartj\/ehu315","article-title":"Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction","volume":"35","author":"Dorfs","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2015.01.063","article-title":"Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction","volume":"183","author":"Yap","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m\u2013pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.healun.2013.09.004","article-title":"Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis","volume":"33","author":"Gray Gilstrap","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12265-015-9613-9","article-title":"Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis","volume":"8","author":"Damy","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cardfail.2016.12.006_bib0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641631243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641631243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:59:32Z","timestamp":1536159572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191641631243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S107191641631243X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2016.12.006","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}